We count visits as totals without cookies, and never follow you from one day to the next. If you accept, we also use cookies to see how people use this site, so we can improve it. Privacy policy
Shows where this fund stands in its group. Not investment advice · Data as of 16 Nov 2026
NAV per unit
NAV (THB/unit) · 13 Nov 20264.7723YTD+0.5550 (+13.16%)
Risk
7
MDD
−14.0%
Dividend
Pays
AUM
91.57M
0.00%
NAV change over the selected periodN/A
Invests across funds within the same AMCComes with insurance benefitsSector fundSSF · Tax-deductibleCurrency hedged 82.39%
What it invests in
Fact sheet data as of 30 Sep 2026
SCBIHEALTH(SSF) invests through the master fund BNP Paribas Funds Health Care Innovators 98.77%
Master fund data as of 30 Sep 2026
This fund
SCBIHEALTH(SSF)
Invests in units of another fund
→
The fund that actually invests
BNP Paribas Funds Health Care Innovators
I Capitalisation · Luxembourg
This fund and the master fund each charge their own fees. See the fees section of this page for the actual fees
The fund spreads its money across many companies
Top 10 companies combined 53.40% of fund value
Other stocks and cash
The fund's allocation: Eli Lilly and Co 9.59%, Merck & 6.49%, ABBVIE 6.48%, AstraZeneca 5.99%, Gilead Sciences 5.08%, Vertex Pharmaceuticals 4.83%, Intuitive Surgical 4.32%, Thermo Fisher 4.12%, Jazz Pharmaceuticals 3.40%, argenx 3.12%, and other stocks and cash 46.60%
Past performance is not a guarantee of future results
Go deeper
Yearly returns
Up in 1 of 4 years · best 2025 +2.54% · worst 2022 −33.41%
Monthly returns
Positive months: 30 of 63 (48%) · Best Dec 2023 +10.19% · Worst Jan 2022 −23.40%
Tap a year to see its months · * part year
Year
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2026
−3.4
+0.7
−3.8
−2.9
+2.8
+7.3
−1.5
+4.7
−0.5
+8.1
+1.8
·
2025
+5.6
+0.3
−8.5
−5.9
−4.2
−1.3
+1.2
+2.3
+1.4
+9.6
+7.7
−3.9
2024
−3.6
+1.9
+3.0
−6.8
−1.3
+2.9
−0.1
+2.0
−1.7
−2.7
+4.9
−5.4
2023
+3.1
−6.2
+0.2
+1.1
−2.3
+0.1
+3.5
−10.8
−10.0
−12.8
+7.5
+10.2
2022
−23.4
−0.7
+4.9
−15.0
−4.4
−1.6
+7.5
+1.8
−6.9
+1.9
+2.2
−1.6
2021
·
·
·
·
·
·
·
·
−7.8
−1.5
−6.7
−6.8
Average
−4.3
−0.8
−0.9
−5.9
−1.9
+1.5
+2.1
−0.0
−4.2
+0.4
+2.9
−1.5
Holding returns: worst · median · best
Every start date since 17 Sep 2021 · 3 and 6 months are total % · 1 year and over is % per year
Worst to best (green = gain, red = loss)Half of all outcomes fall in this rangeMedian
Risk
Drawdown from peak
Largest drawdown in the selected period −66.36%Previous peak 17 Sep 2021 (NAV 10.2795) → Trough 8 Aug 2025 (NAV 3.4581) · Not back to the previous peak as of 13 Nov 2026
Currently −53.57% from the peak NAV of 10.2795 (17 Sep 2021)
Change between the 2 points
Below the previous peakLargest drawdown period (previous peak → recovery)Drawdown = NAV ÷ highest prior NAV in the selected period − 1Drag across the chart to pick 2 points (on a phone, hold with 2 fingers)
Go deeper
Return vs SD
Over 1 year, SCBIHEALTH(SSF) returned 0.80 per unit of SD, ranking 10 of 12 funds · The highest is BCARESSF (1.28)
กองทุนมีนโยบายเน้นลงทุนในหน่วยลงทุนของกองทุนรวมต่างประเทศเพียงกองทุนเดียว (Feeder Fund) ได้แก่ กองทุน BNP Paribas Funds Health Care Innovators - Class I Capitalisation (กองทุนหลัก) ในสกุลเงินยูโร (EUR) Its largest holdings are หน่วยลงทุน BNP HEALTH CARE INNOV-I 98.77% (fact sheet 30 Sep 2026)
How risky is it?+−
Risk level 7 of 8 (High risk). Since 17 Sep 2021, its NAV has fallen as much as −66.36% from its peak.
What are the fees?+−
Actual total expense ratio (TER) 1.71% a year, against a ceiling of 2.90%. Management fee 1.61%. Front-end fee 0.00%. Back-end fee 0.00%. (Fact sheet 31 Aug 2026)
Does it pay dividends?+−
It has a dividend policy but has not paid any dividends yet
What is the minimum purchase, and when do I get my money after selling?+−
Minimum first purchase 1,000 THB, subsequent purchases 1,000 THB. Buy orders accepted until 15:30, sell orders until 15:30, and redemption proceeds are paid T+4
Does it hedge currency risk?+−
Hedged at the manager's discretion. As of 30 Sep 2026, 82.39% of the value of its foreign investments was hedged
How is SCBIHEALTH(SSF) different from SCBIHEALT(SSFE) / SCBIHEALTH(A) / SCBIHEALTH(D) / SCBIHEALTH(E) / SCBIHEALTH(IN) / SCBIHEALTH(P) / SCBIHEALTH(R)?+−
They are share classes of the same fund and invest in the same assets. They differ only in each class's terms, such as dividend policy, fees or who can buy · SCBIHEALTH(SSF): pays dividends, TER 1.71% · SCBIHEALT(SSFE): pays dividends, TER 0.11% · SCBIHEALTH(A): no dividends, TER 1.71% · SCBIHEALTH(D): see the conditions in the prospectus · SCBIHEALTH(E): no dividends, TER 0.11% · SCBIHEALTH(IN): see the conditions in the prospectus · SCBIHEALTH(P): no dividends, TER 0.10% · SCBIHEALTH(R): see the conditions in the prospectus
Warning Past performance is not a guarantee of future results · Investing involves risk. Investors should understand the product's features, return conditions and risks before making an investment decision · This fund invests abroad, so investors may lose or gain from exchange rate movements
Based on the master fund's share of this fund's value (98.77% as of 31 Aug 2026) × each stock's weight in the master fund · stocks as of 30 Sep 2026 · fact sheet from BNP Paribas · Illustrations are for explanation only, not individual stock recommendations
Each bar is one fund in the AIMC Health Care group, sorted from highest to lowest return · Only SSF share classes are counted, and only funds with a full track record for the period are included · Calculated from NAV as of 16 Nov 2026